Apellis Pharmaceuticals Aktie
27,88
EUR
-1,19
EUR
-4,08
%
29,00
USD
-1,38
USD
-4,54
%
Werbung
Apellis Pharmaceuticals Aktie Analyse
01.08.19 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
30.07.18 | Apellis Pharmaceuticals Buy | B. Riley FBR | |
24.05.18 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
08.02.18 | Apellis Pharmaceuticals Buy | B. Riley FBR, Inc. |
Werbung
Werbung